Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-03

Clinical Trial Update: Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 trial update focusing on minimizing glucocorticoid use in patients with proliferative lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institutul Clinic Fundeni | Conditions: Lupus Nephritis | Phase 4 | Status: RECRUITING